Samir Khleif is Founder, President, and CEO of Georgiamune, a biotech reprogramming immune signaling pathways to restore health.
A medical oncologist, immunologist, and global leader in immunotherapy, he has held senior roles at the NIH, FDA, King Hussein Cancer Center, and Georgia Cancer Center. Currently a professor at Georgetown University Medical School, Samir has authored hundreds of scientific papers, holds over 150 patents, and advises leading cancer research initiatives worldwide.
.png)
